dr. tam discusses btk inhibition in cll
Published 7 years ago • 142 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
1:49
dr. tam on btk inhibitor bgb-3111 in cll
-
2:10
dr. tam on fda approved btk inhibitors in hematologic malignancies
-
5:03
next-generation btk inhibitor for chronic lymphocytic leukemia (cll) - dr. constantine tam ash 2021
-
3:57
btk inhibitors in chronic lymphocytic leukemia
-
3:25
btk inhibitors in cll: treatment selection
-
5:06
evolution of btk inhibitors in cll
-
4:54
second-generation btk inhibitors in cll
-
1:28
dr. ma on the utility of btk inhibitors in relapsed/refractory cll
-
1:15
dr. flinn on the role of btk inhibitors in cll
-
9:00
btk inhibitors in cll: ibrutinib
-
4:26
btk inhibitors in relapsed/refractory cll
-
1:13
dr. hill discusses btk inhibitors in mantle cell lymphoma
-
5:30
rationale for btk inhibition in cll
-
1:22
dr. ghosh on unanswered questions with btk inhibitors in cll/sll
-
0:48
dr. byrd on bruton's tyrosine kinase in chronic lymphocytic leukemia
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
1:00
dr. seymour on the kinase selectivity of btk inhibitors in cll
-
1:26
the expanding landscape of next-generation btk inhibitors in cll
-
33:30
bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: context and impact of new data